FTO and head and neck squamous cell carcinoma: The results revealed that the expression levels of YTHDF1, METTL3, KIAA1429, YTHDF2, RBM15, METTL14, ALKBH5, FTO, WTAP, and HNRNPC were significantly upregulated in head and neck squamous cell carcinoma samples, while YTHDC2 was remarkably downregulated (Zhao and Cui, 2019).